1. Punicic acid modulates mucosal immune responses and prevents gut inflammation through PPAR γ and δ‐dependent mechanisms
- Author
-
Josep Bassaganya-Riera, Cristina Vives, Elisa Duran, Sandra Sánchez, Montse Climent, Marianne O'Shea, Marcel Orpi, Alexandra W. C. Einerhand, Raquel Hontecillas, Anibal de Horna, and Maggie Diguardo
- Subjects
chemistry.chemical_classification ,Punicic acid ,Peroxisome proliferator-activated receptor ,Biochemistry ,chemistry.chemical_compound ,medicine.anatomical_structure ,Immune system ,chemistry ,Nuclear receptor ,RAR-related orphan receptor gamma ,Genetics ,Cancer research ,medicine ,Mesenteric lymph nodes ,Keratinocyte growth factor ,Receptor ,Molecular Biology ,Biotechnology - Abstract
Punicic acid (PUA) is a conjugated linolenic acid isomer that has shown promise in suppressing gut inflammation. The goal of this study is to elucidate the mechanisms by which PUA modulates mucosal immunity and prevents or ameliorates gut inflammation. The expression of peroxisome proliferator-activated receptor (PPAR) α, γ and δ and their responsive genes was examined in the colonic mucosa of two mouse models of experimental inflammatory bowel disease (IBD). Immune cell-specific PPAR γ null, PPAR δ null and wild-type (WT) mice were administered control or PUA-supplemented diets and challenged with 2.5% DSS. The phenotype of immune cell subsets was examined in the mucosal and peripheral immune system. The prophylactic efficacy of PUA was also examined in an IL-10−/− model of IBD. PUA intake upregulated colonic PPAR δ, keratinocyte growth factor and the orphan nuclear receptor RORγt expression and suppressed colonic and M1 macrophage-derived TNF-α. In the mesenteric lymph nodes (i.e., mucosal inductive sit...
- Published
- 2010
- Full Text
- View/download PDF